SCHEMBL30038758

CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)C(C)C

nearest known ligand 0.67

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	VIPR1	P32241	4/20	0.63

▸	GLP1R	P43220	2/20	0.62

▸	GCGR	P47871	1/20	0.62

▸	GIPR	P48546	1/20	0.62

▸	TFPI	P10646	1/20	0.62

▸	VIPR2	P41587	6/20	0.62

▸	KISS1R	Q969F8	3/20	0.58

▸	CCKBR	P32239	1/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30037373	0.96	TFPI (0.63)	VIPR1GLP1RGCGRGIPRTFPI
SCHEMBL30037677	0.95	TFPI (0.62)	VIPR1GLP1RGCGRGIPRTFPI
SCHEMBL29854527	0.93	VIPR1 (0.65)	VIPR1GLP1RGCGRGIPRTFPI
SCHEMBL27043239	0.92	TFPI (0.68)	VIPR1GLP1RGCGRGIPRTFPI
SCHEMBL29416557	0.92	TFPI (0.68)	VIPR1GLP1RGCGRGIPRTFPI
SCHEMBL30432341	0.92	GLP1R (0.63)	VIPR1GLP1RGCGRGIPRTFPI
SCHEMBL31182595	0.92	GLP1R (0.68)	VIPR1GLP1RGCGRGIPRTFPI
SCHEMBL30906402	0.91	VIPR1 (0.61)	VIPR1GLP1RGCGRGIPRTFPI
SCHEMBL30480570	0.91	VIPR1 (0.66)	VIPR1GLP1RGCGRGIPRTFPI
SCHEMBL29453341	0.91	VIPR1 (0.72)	VIPR1GLP1RGCGRGIPRTFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4329827-A1	TARGETING SYSTEM FOR CANCER COMPRISING A RADIOISOTOPE	Alphathera AG (CH)	2024-03-06	—	—	EP	claimed
WO-2022231424-A1	TARGETING SYSTEM FOR CANCER COMPRISING A RADIOISOTOPE	ALPHATHERA AG (CH)	2022-11-03	—	—	WO	claimed